,
Sakr, Yasser https://orcid.org/0000-0003-3163-1334
Bauer, Michael
Nierhaus, Axel
Kluge, Stefan
Schumacher, Ulricke
Putensen, Christian
Fichtner, Falk
Petros, Sirak
Scheer, Christian
Jaschinski, Ulrich
Tanev, Ivan
Jacob, David
Weiler, Norbert
Schulze, P. Christian
Fiedler, Fritz
Kapfer, Barbara
Brunkhorst, Frank
Lautenschlaeger, Ingmar
Wartenberg, Katja
Utzolino, Stefan
Briegel, Josef
Moerer, Onnen
Bischoff, Petra
Zarbock, Alexander
Quintel, Michael
Gattinoni, Luciano
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG SA 2167/3-1)
Grifols SA (NA)
Dept. of Anesthesiology and Intensive Care, Jena University Hospital (NA)
Article History
Received: 29 June 2020
Accepted: 19 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: The leading Ethics Committee (EC) is the EC responsible for the Sponsor site (University of Jena, Bachstrasse 18, 07740 Jena, Germany) which has approved the current version of the protocol (Reg.-Nr.: 2018-1227-AMG_ff. Protokoll-Nr.: ZKSJ0122_ARISS). The ECs of the respective centres should approve the study protocol before recruitment of patients begins in each centre. Informed consent will be obtained from all study participants or their legal representatives.
: Non applicable
: S. Kluge received research support by Ambu, E.T.View Ltd., Fisher & Paykel, Pfizer, and Xenios. He also received lecture honorarium from Arjo Huntleigh, Astellas, Astra, Basilea, Bard, Baxter, Biotest, CSL Behring, Cytosorbents, Fresenius, Gilead, MSD, Orion, Pfizer, Philips, Sedana, Sorin, Xenios, and Zoll. He received consultant honorarium from AMOMED, Astellas, Baxter, Bayer, Fresenius, Gilead, MSD, Pfizer, and Xenios. Y Sakr received consultation and lecture honorarium from Grifols S.A., in addition to the support supplied for the current trial. All other others declare that they do not have conflict of interest in relation to the subject of the current manuscript.